Global and United States Meningococcal Infections Vaccine Market Report & Forecast 2023-2028

Report ID: 1830460 | Published Date: Jan 2025 | No. of Page: 66 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Meningococcal Infections Vaccine Revenue in Meningococcal Infections Vaccine Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Meningococcal Infections Vaccine Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Meningococcal Infections Vaccine Market Size for the Year 2017-2028
        1.2.2 Global Meningococcal Infections Vaccine Market Size for the Year 2017-2028
    1.3 Meningococcal Infections Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Meningococcal Infections Vaccine in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Meningococcal Infections Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Meningococcal Infections Vaccine Market Dynamics
        1.4.1 Meningococcal Infections Vaccine Industry Trends
        1.4.2 Meningococcal Infections Vaccine Market Drivers
        1.4.3 Meningococcal Infections Vaccine Market Challenges
        1.4.4 Meningococcal Infections Vaccine Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Meningococcal Infections Vaccine by Type
    2.1 Meningococcal Infections Vaccine Market Segment by Type
        2.1.1 Quadrivalent (Serogroups A, C, W-135, and Y)
        2.1.2 Bivalent (Serogroups C and Y)
        2.1.3 Serogroup A
        2.1.4 Serogroup B
        2.1.5 Serogroup X
    2.2 Global Meningococcal Infections Vaccine Market Size by Type (2017, 2022 & 2028)
    2.3 Global Meningococcal Infections Vaccine Market Size by Type (2017-2028)
    2.4 United States Meningococcal Infections Vaccine Market Size by Type (2017, 2022 & 2028)
    2.5 United States Meningococcal Infections Vaccine Market Size by Type (2017-2028)
3 Meningococcal Infections Vaccine by Application
    3.1 Meningococcal Infections Vaccine Market Segment by Application
        3.1.1 Hospital
        3.1.2 Clinic
    3.2 Global Meningococcal Infections Vaccine Market Size by Application (2017, 2022 & 2028)
    3.3 Global Meningococcal Infections Vaccine Market Size by Application (2017-2028)
    3.4 United States Meningococcal Infections Vaccine Market Size by Application (2017, 2022 & 2028)
    3.5 United States Meningococcal Infections Vaccine Market Size by Application (2017-2028)
4 Global Meningococcal Infections Vaccine Competitor Landscape by Company
    4.1 Global Meningococcal Infections Vaccine Market Size by Company
        4.1.1 Top Global Meningococcal Infections Vaccine Companies Ranked by Revenue (2021)
        4.1.2 Global Meningococcal Infections Vaccine Revenue by Player (2017-2022)
    4.2 Global Meningococcal Infections Vaccine Concentration Ratio (CR)
        4.2.1 Meningococcal Infections Vaccine Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Meningococcal Infections Vaccine in 2021
        4.2.3 Global Meningococcal Infections Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Meningococcal Infections Vaccine Headquarters, Revenue in Meningococcal Infections Vaccine Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Meningococcal Infections Vaccine Headquarters and Area Served
        4.3.2 Global Meningococcal Infections Vaccine Companies Revenue in Meningococcal Infections Vaccine Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Meningococcal Infections Vaccine Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Meningococcal Infections Vaccine Market Size by Company
        4.5.1 Top Meningococcal Infections Vaccine Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Meningococcal Infections Vaccine Revenue by Players (2020, 2021 & 2022)
5 Global Meningococcal Infections Vaccine Market Size by Region
    5.1 Global Meningococcal Infections Vaccine Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Meningococcal Infections Vaccine Market Size by Region (2017-2028)
        5.2.1 Global Meningococcal Infections Vaccine Market Size by Region: 2017-2022
        5.2.2 Global Meningococcal Infections Vaccine Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Meningococcal Infections Vaccine Market Size YoY Growth 2017-2028
        6.1.2 North America Meningococcal Infections Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Meningococcal Infections Vaccine Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Meningococcal Infections Vaccine Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Meningococcal Infections Vaccine Market Size YoY Growth 2017-2028
        6.3.2 Europe Meningococcal Infections Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Meningococcal Infections Vaccine Market Size YoY Growth 2017-2028
        6.4.2 Latin America Meningococcal Infections Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Meningococcal Infections Vaccine Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Meningococcal Infections Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Creative Biolabs(USA)
        7.1.1 Creative Biolabs(USA) Company Details
        7.1.2 Creative Biolabs(USA) Business Overview
        7.1.3 Creative Biolabs(USA) Meningococcal Infections Vaccine Introduction
        7.1.4 Creative Biolabs(USA) Revenue in Meningococcal Infections Vaccine Business (2017-2022)
        7.1.5 Creative Biolabs(USA) Recent Development
    7.2 SERUM INSTITUTE OF INDIA PVT.LTD.(India)
        7.2.1 SERUM INSTITUTE OF INDIA PVT.LTD.(India) Company Details
        7.2.2 SERUM INSTITUTE OF INDIA PVT.LTD.(India) Business Overview
        7.2.3 SERUM INSTITUTE OF INDIA PVT.LTD.(India) Meningococcal Infections Vaccine Introduction
        7.2.4 SERUM INSTITUTE OF INDIA PVT.LTD.(India) Revenue in Meningococcal Infections Vaccine Business (2017-2022)
        7.2.5 SERUM INSTITUTE OF INDIA PVT.LTD.(India) Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Meningococcal Infections Vaccine Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Meningococcal Infections Vaccine Market Trends
    Table 3. Meningococcal Infections Vaccine Market Drivers
    Table 4. Meningococcal Infections Vaccine Market Challenges
    Table 5. Meningococcal Infections Vaccine Market Restraints
    Table 6. Global Meningococcal Infections Vaccine Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Meningococcal Infections Vaccine Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Meningococcal Infections Vaccine Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Meningococcal Infections Vaccine Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Meningococcal Infections Vaccine Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Meningococcal Infections Vaccine Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Meningococcal Infections Vaccine Revenue Share by Player, 2017-2022
    Table 13. Global Meningococcal Infections Vaccine Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Meningococcal Infections Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Infections Vaccine as of 2021)
    Table 15. Top Players of Meningococcal Infections Vaccine in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Meningococcal Infections Vaccine Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Meningococcal Infections Vaccine Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Meningococcal Infections Vaccine Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Meningococcal Infections Vaccine Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Meningococcal Infections Vaccine Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Meningococcal Infections Vaccine Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Meningococcal Infections Vaccine Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Meningococcal Infections Vaccine Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Meningococcal Infections Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Meningococcal Infections Vaccine Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Meningococcal Infections Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Meningococcal Infections Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Meningococcal Infections Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Creative Biolabs(USA) Company Details
    Table 31. Creative Biolabs(USA) Business Overview
    Table 32. Creative Biolabs(USA) Meningococcal Infections Vaccine Product
    Table 33. Creative Biolabs(USA) Revenue in Meningococcal Infections Vaccine Business (2017-2022) & (US$ Million)
    Table 34. Creative Biolabs(USA) Recent Development
    Table 35. SERUM INSTITUTE OF INDIA PVT.LTD.(India) Company Details
    Table 36. SERUM INSTITUTE OF INDIA PVT.LTD.(India) Business Overview
    Table 37. SERUM INSTITUTE OF INDIA PVT.LTD.(India) Meningococcal Infections Vaccine Product
    Table 38. SERUM INSTITUTE OF INDIA PVT.LTD.(India) Revenue in Meningococcal Infections Vaccine Business (2017-2022) & (US$ Million)
    Table 39. SERUM INSTITUTE OF INDIA PVT.LTD.(India) Recent Development
    Table 40. Research Programs/Design for This Report
    Table 41. Key Data Information from Secondary Sources
    Table 42. Key Data Information from Primary Sources
List of Figures
    Figure 1. Meningococcal Infections Vaccine Product Picture
    Figure 2. Global Meningococcal Infections Vaccine Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Meningococcal Infections Vaccine Market Size 2017-2028 (US$ Million)
    Figure 4. United States Meningococcal Infections Vaccine Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Meningococcal Infections Vaccine Market Size 2017-2028 (US$ Million)
    Figure 6. United States Meningococcal Infections Vaccine Market Share in Global 2017-2028
    Figure 7. Meningococcal Infections Vaccine Report Years Considered
    Figure 8. Product Picture of Quadrivalent (Serogroups A, C, W-135, and Y)
    Figure 9. Product Picture of Bivalent (Serogroups C and Y)
    Figure 10. Product Picture of Serogroup A
    Figure 11. Product Picture of Serogroup B
    Figure 12. Product Picture of Serogroup X
    Figure 13. Global Meningococcal Infections Vaccine Market Share by Type in 2022 & 2028
    Figure 14. Global Meningococcal Infections Vaccine Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. Global Meningococcal Infections Vaccine Market Share by Type (2017-2028)
    Figure 16. United States Meningococcal Infections Vaccine Market Share by Type in 2022 & 2028
    Figure 17. United States Meningococcal Infections Vaccine Market Size by Type (2017-2028) & (US$ Million)
    Figure 18. United States Meningococcal Infections Vaccine Market Share by Type (2017-2028)
    Figure 19. Product Picture of Hospital
    Figure 20. Product Picture of Clinic
    Figure 21. Global Meningococcal Infections Vaccine Market Share by Application in 2022 & 2028
    Figure 22. Global Meningococcal Infections Vaccine Market Size by Application (2017-2028) & (US$ Million)
    Figure 23. Global Meningococcal Infections Vaccine Market Share by Application (2017-2028)
    Figure 24. United States Meningococcal Infections Vaccine Market Share by Application in 2022 & 2028
    Figure 25. United States Meningococcal Infections Vaccine Market Size by Application (2017-2028) & (US$ Million)
    Figure 26. United States Meningococcal Infections Vaccine Market Share by Application (2017-2028)
    Figure 27. North America Meningococcal Infections Vaccine Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 28. U.S. Meningococcal Infections Vaccine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Canada Meningococcal Infections Vaccine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Europe Meningococcal Infections Vaccine Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 31. Germany Meningococcal Infections Vaccine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. France Meningococcal Infections Vaccine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. U.K. Meningococcal Infections Vaccine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Italy Meningococcal Infections Vaccine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Russia Meningococcal Infections Vaccine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Meningococcal Infections Vaccine Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 37. China Meningococcal Infections Vaccine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Japan Meningococcal Infections Vaccine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. South Korea Meningococcal Infections Vaccine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. India Meningococcal Infections Vaccine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Australia Meningococcal Infections Vaccine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Taiwan Meningococcal Infections Vaccine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Indonesia Meningococcal Infections Vaccine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Thailand Meningococcal Infections Vaccine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Malaysia Meningococcal Infections Vaccine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Philippines Meningococcal Infections Vaccine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Latin America Meningococcal Infections Vaccine Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 48. Mexico Meningococcal Infections Vaccine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Brazil Meningococcal Infections Vaccine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Argentina Meningococcal Infections Vaccine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Middle East & Africa Meningococcal Infections Vaccine Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 52. Turkey Meningococcal Infections Vaccine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Meningococcal Infections Vaccine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. U.A.E Meningococcal Infections Vaccine Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Creative Biolabs(USA) Revenue Growth Rate in Meningococcal Infections Vaccine Business (2017-2022)
    Figure 56. SERUM INSTITUTE OF INDIA PVT.LTD.(India) Revenue Growth Rate in Meningococcal Infections Vaccine Business (2017-2022)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Creative Biolabs(USA)
SERUM INSTITUTE OF INDIA PVT.LTD.(India)
Frequently Asked Questions
Meningococcal Infections Vaccine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Meningococcal Infections Vaccine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Meningococcal Infections Vaccine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Hydro Generator

Hydro Generator market is segmented by region (country), players, by Type and by Application. Pla ... Read More

Tin Bronze

Tin Bronze market is segmented by region (country), players, by Type and by Application. Players, ... Read More